Psoriasis and vascular disease-risk factors and outcomes: A systematic review of the literature

Journal of General Internal Medicine

Volumn 26, Issue 9, 2011, Pages 1036-1049

  Patel, Rita V ^a   Shelling, Michael L ^a   Prodanovich, Srdjan ^a   Federman, Daniel G ^b,c   Kirsner, Robert S ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b VA Connecticut Health Care ^*  (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

alcohol; cardiovascular disease; cohort based studies; cross sectional studies; psoriasis; risk factors

Indexed keywords

ADIPONECTIN; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; ANTIOXIDANT; ANTITHROMBIN III; APOLIPOPROTEIN B; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C PEPTIDE; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; CERULOPLASMIN; CORTICOSTEROID; CYANOCOBALAMIN; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRINOGEN; FIBRONECTIN; FOLIC ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN; HOMOCYSTEINE; INSULIN; LEPTIN; LOW DENSITY LIPOPROTEIN; TISSUE PLASMINOGEN ACTIVATOR; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; URIC ACID; VERY LOW DENSITY LIPOPROTEIN;

ALCOHOL CONSUMPTION; ALCOHOLISM; ANGINA PECTORIS; ARTERIAL WALL THICKNESS; ARTHROPATHY; ASTHMA; ATHEROSCLEROSIS; BILE REFLUX; BODY FAT; BODY MASS; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CEREBROVASCULAR DISEASE; CERULOPLASMIN BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; COMORBIDITY; CORONARY ARTERY CALCIFICATION; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DIASTOLIC DYSFUNCTION; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; ENVIRONMENTAL EXPOSURE; ERYTHROCYTE SEDIMENTATION RATE; EXERCISE; FAMILY HISTORY; FIBRINOGEN BLOOD LEVEL; GENETIC PREDISPOSITION; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HEART DISEASE; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART RATE; HOSPITALIZATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERHOMOCYSTEINEMIA; HYPERLEPTINEMIA; HYPERLIPIDEMIA; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; LIVER CIRRHOSIS; LUNG CANCER; METABOLIC SYNDROME X; MITRAL VALVE REGURGITATION; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; OUTCOME ASSESSMENT; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PNEUMONIA; POLYPHARMACY; PSORIASIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; REVIEW; RHEUMATOID ARTHRITIS; RISK FACTOR; SEX DIFFERENCE; SKIN DISEASE; SMOKING; SPINE DISEASE; STROKE; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; TRICUSPID VALVE REGURGITATION; ULTRAVIOLET B RADIATION; URTICARIA; VASCULAR DISEASE; VIRUS INFECTION;

CASE-CONTROL STUDIES; COHORT STUDIES; HUMANS; PROSPECTIVE STUDIES; PSORIASIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; TREATMENT OUTCOME; VASCULAR DISEASES;

EID: 80052274292     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-011-1698-5     Document Type: Review

References (106)

1. National Psoriasis Foundation. Psoriasis statistics. Available at www.psoriasis.org/about/stats. Accessed March 11, 2011
2. M Esposito R Saraceno A Guinta M Maccarone S Chimenti 2006 An Italian study on psoriasis and depression Dermatology. 212 2 123 7 16484818 (Pubitemid 43260727)
3. PA Russo R Ilchef AJ Cooper 2004 Psychiatric morbidity in psoriasis: a review Australas J Dermatol. 45 3 155 9 15250891
4. AB Kimball C Jacobson C Weiss MG Vreeland Y Wu 2005 The psychosocial burden of psoriasis Am J Clin Dermatol. 6 6 383 92 16343026 (Pubitemid 43128290)
5. H Kremers MT McEvoy FJ Dann SE Gabriel 2007 Heart disease in psoriasis J Am Acad Dermatol. 57 2 347 54 17433490 (Pubitemid 47048862)
6. E Svenungsson K Jensen-Urstad M Heimbürger A Silveira A Hamsten U de Faire, et al. 2001 Risk factors for cardiovascular disease in systemic lupus erythematosus Circulation. 104 16 1887 93 11602489 1:STN:280: DC%2BD3MrlsFGmsg%3D%3D (Pubitemid 32983229)
7. S Wallberg-Jonsson ML Ohman SR Dahlqvist 1997 Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden J Rheumatol. 24 3 445 51 9058647 1:STN:280:DyaK2s3htFKrsg%3D%3D (Pubitemid 27153406)
8. Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Available at www.ohri.ca/programs/clinical- epidemiology/oxford.htm. Accessed March 11, 2011
9. J Shapiro AD Cohen M David E Hodak G Chodik A Viner, et al. 2007 The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: A case-control study J Am Acad Dermatol. 56 4 629 34 17157411 (Pubitemid 46400186)
10. C Gonzalez-Juanatey J Lorca JA Mirando-Filloy E Amigo-Diaz A Testa C Garcia-Porrua, et al. 2007 Endothelial dysfunction in psoriatic arthritis patients without clinically evident cardiovascular disease or classic arthrosclerosis risk factors Arthritis Rheum 57 2 287 93 17330278 1:CAS:528:DC%2BD2sXktVaqsrk%3D (Pubitemid 47164092)
11. C Gonzalez-Juanatey J Lorca E Amigo-Diaz T Dierssen M Javier M Gonzalez-Gay 2007 High prevalence of subclinical atherosclerosis in psoriatic arthritis patients without clinical evident cardiovascular disease or classic arthrosclerosis risk factors Arthritis Rheum 57 6 1074 80 17665475 (Pubitemid 47237336)
12. D Balci A Balci S Karazincir E Ucar U Iyigun F Yalcin, et al. 2009 Increased carotid artery intima-media thickness and impaired endothelial function in psoriasis J Eur Acad Dermatol Venereol. 23 1 1 6 18702627 1:CAS:528:DC%2BC3cXlslWlt7g%3D
13. O Kimhi D Caspi NM Bornstein N Maharshak A Gur Y Arbel, et al. 2007 Prevalence and risk factors of atherosclerosis in patients with psoriatic arthritis Semin Arthritis Rheum. 36 4 203 9 17067658 (Pubitemid 46188476)
14. H Yalcin DD Balci E Ucar N Ozcelik C Tasci E Seyfeli, et al. 2009 Myocardial perfusion is preserved in patients with psoriasis without clinically evident cardiovascular disease J Eur Acad Dermatol Venereol. 23 7 798 802 19470047 1:STN:280:DC%2BD1Mris1artg%3D%3D
15. BS Uyanik Z Ari E Onur K Gündüz S Tanülkü K Durkan 2002 Serum lipids and apolipoproteins in patients with psoriasis Chin Chem Lab Med. 40 1 65 8 1:CAS:528:DC%2BD38Xis1OgtL0%3D (Pubitemid 34196452)
16. JA Kaye L Li SS Jick 2008 Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis Br J Dermatol. 159 4 895 902 18616778 1:STN:280:DC%2BD1cnktF2qtw%3D%3D
17. L Mallbris F Granath A Hamsten M Ståhle 2006 Psoriasis is associated with lipid abnormalities at the onset of skin disease J Am Acad Dermatol. 54 4 614 21 16546581
18. S Piskin F Gurkok G Ekuklu M Senol 2003 Serum lipid levels in psoriasis Yonsei Med J. 44 1 24 6 12619171 1:CAS:528:DC%2BD3sXislKnsLw%3D (Pubitemid 36322510)
19. C Reynoso-von Drateln E Martínez-Abundis BR Balcázar- Muñoz R Bustos-Saldaña M González-Ortiz 2003 Lipid profile, insulin secretion, and insulin sensitivity in psoriasis J Am Acad Dermatol 48 6 822 5
20. J Dreiher D Weitzman B Davidovici J Shapiro AD Cohen 2008 Psoriasis and dyslipidaemia: a population-based study Acta Derm Venereol. 88 6 561 5 19002339 1:CAS:528:DC%2BD1MXjsVKmu7w%3D
21. A Pietrzak J Kadzielewski K Janowski J Roliński D Krasowska G Chodorowska, et al. 2009 Lipoprotein (a) in patients with psoriasis: associations with lipid profiles and disease severity Int J Dermatol. 48 4 379 87 19335423 1:CAS:528:DC%2BD1MXlt1GitLk%3D
22. M Akhyani AH Ehsani RM Robati AM Robati 2007 The lipid profile in psoriasis: a controlled study J Eur Acad Dermatol Venereol. 21 10 1330 2 17958837 1:STN:280:DC%2BD2snjsFSgtw%3D%3D (Pubitemid 350020138)
23. SM Jones PD Harris J Lloyd CA Stirling JP Reckless NJ McHugh 2000 Lipoproteins and their subfractions in psoriatic arthritis: identification of an atherogenic profile with active joint disease Ann Rheum Dis. 59 11 904 9 11053070 1:CAS:528:DC%2BD3cXos1ylsL0%3D
24. P Rocha-Pereira A Santos-Silva I Rebelo A Figueiredo A Quintanilha F Teixeira 2001 Dyslipidemia and oxidative stress in mild and severe psoriasis as a risk for cardiovascular disease Clin Chim Acta. 303 1-2 33 9 11163020 1:CAS:528:DC%2BD3MXksVWntQ%3D%3D (Pubitemid 32121803)
25. C Han DW Robinson MV Hackett LC Paramore KH Fraeman MV Bala 2006 Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis J Rheumatol. 33 11 2167 72 16981296 (Pubitemid 44749774)
26. AB Kimball D Robinson Y Wu C Guzzo N Yeilding C Paramore, et al. 2008 Cardiovascular disease and risk factors among psoriasis patients in two US healthcare databases, 2001-2002 Dermatology. 217 1 27 37 18349542 1:STN:280:DC%2BD1cvgvVyjtg%3D%3D (Pubitemid 351896565)
27. AL Neimann DB Shin X Wang DJ Margolis AB Troxel JM Gelfand 2006 Prevalence of cardiovascular risk factors in patients with psoriasis J Am Acad Dermatol. 55 5 829 35 17052489 (Pubitemid 44556851)
28. B Vanizor Kural A Orem G Cimsit HA Uydu YE Yanid A Alver 2003 Plasma homocysteine and its relationships with atherothrombotic markers in psoriatic patients Clin Chim Acta 332 1-2 23 30 12763276 1:CAS:528:DC%2BD3sXjvV2msbo%3D (Pubitemid 36577485)
29. M Malerba P Gisondi A Radaeli R Sala PG Calzavara Pinton G Girlomoni 2006 Plasma homocysteine and folate levels in patients with chronic plaque type psoriasis Br J Dermatol. 155 6 1165 9 17107384 1:CAS:528:DC%2BD2sXntVagsA%3D%3D (Pubitemid 44729990)
30. SK Cakmak U Gül C Kiliç M Gönül S Soylu A Kiliç 2009 Homocysteine, vitamin B12 and folic acid levels in psoriasis patients J Eur Acad Dermatol Venereol. 23 3 300 3 19207655 1:CAS:528: DC%2BC3cXlslWltrY%3D
31. PM Ridker 2001 High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease Circulation. 103 13 1813 8 11282915 1:CAS:528:DC%2BD3MXjsFKisbk%3D (Pubitemid 32291421)
32. T Ohtsuka 2008 The relation between high-sensitivity C-reactive protein and maximum body mass index in patients with psoriasis Br J Dermatol. 158 5 1141 3 18284386 1:STN:280:DC%2BD1c3ksFWgtg%3D%3D (Pubitemid 351521435)
33. I Biyik A Narin MA Bozok O Ergene 2006 Echocardiographic and clinical abnormalities in patients with psoriasis J Intl Med Res. 34 6 632 9 1:STN:280:DC%2BD2s%2FpslSiuw%3D%3D (Pubitemid 46165387)
34. AA Qureshi HK Choi AR Setty GC Curhan 2009 Psoriasis and the risk of diabetes and hypertension Arch Dermatol. 145 4 379 82 19380659
35. A Gerdes VA Zahl H Knopf M Weichenthal U Mrowietz 2008 Comedication related to comorbidities: a study in 1203 hospitalized patients with severe psoriasis Br J Dermatol. 159 5 1116 23 18717681 1:STN:280:DC%2BD1cjmslWjtQ%3D%3D
36. VC Ho 2004 The use of cyclosporine in psoriasis: a clinical review Br J Dermatol. 150 suppl 67 1 10 15115440 1:CAS:528:DC%2BD2cXlt1Kgur8%3D (Pubitemid 38903573)
37. RE Reeds Jr RM Fusaro I Fisher 1964 Psoriasis vulgaris I: a clinical survey of the association with diabetes mellitus Arch Dermatol. 89 205 8 14081559
38. YB Brauchli SS Jick CR Meier 2008 Psoriasis and the risk of incident diabetes mellitus: a population-based study Br J Dermatol. 159 6 1331 7 18782318 1:STN:280:DC%2BD1cjmslartA%3D%3D
39. Y Wu D Mills M Bala 2008 Psoriasis: cardiovascular risk factors and other disease comorbidities J Drug Dermatol. 7 4 373 7
40. MD Herron M Hinckley MS Hoffman J Papenfuss CB Hansen KP Callis, et al. 2005 Impact of obesity and smoking on psoriasis presentation and management Arch Dermatol. 141 12 1527 34 16365253 (Pubitemid 41815842)
41. K Wolk L Mallbris P Larsson A Rosenblad E Vingård M Ståhle 2009 Excessive body weight and smoking associates with a high risk of onset of plaque psoriasis Acta Derm Venereol. 89 5 492 7 19734975
42. A Johnston S Arnadottir JE Gudjonnson A Aphale AA Sigmarsdottir SI Gunnarsson, et al. 2008 Obesity in psoriasis: leptin and resistin as mediators of cutaneous inflammation Br J Dermatol. 159 2 342 50 18547319 1:CAS:528:DC%2BD1cXhtVCqs7nJ (Pubitemid 352009847)
43. AA Cerman S Bozkurt A Sav A Tulunay MO Elbaşi T Ergun 2008 Serum leptin levels, skin leptin, and leptin receptor expression in psoriasis Br J Dermatol. 159 4 820 6 18637894 1:CAS:528:DC%2BD1cXhtlGitrvL
44. YJ Chen CY Wu JL Shen SY Chu CK Chen YT Chang, et al. 2008 Psoriasis independently associated with hyperleptinemia contributing to metabolic syndrome Arch Dermatol. 144 12 1571 5 19075139
45. Y Jin F Zhang S Yang Y Kong F Xiao Y Hou, et al. 2008 Combined effects of HLA-Cw6, body mass index, and waist-hip ratio on psoriasis vulgaris in Chinese Han population J Dermatol Sci. 52 2 123 9 18585007 1:CAS:528:DC%2BD1cXhtFagurrL
46. S Kaur K Zilmer C Kairane M Kals M Zilmer 2008 Clear differences in adiponectin and glutathione redox status revealed in obese and normal-weight patients with psoriasis Br J Dermatol. 159 6 1364 7 18652586 1:STN:280:DC%2BD1cjms1yqug%3D%3D
47. JW McGowan DJ Pearce J Chen D Richmond R Balkrishnan SR Feldman 2005 The skinny of psoriasis and obesity Arch Dermatol. 141 12 1601 2 16365269
48. ML Murray PR Bergstresser B Adams-Huet JB Cohen 2008 Relationship of psoriasis severity to obesity using same-gender siblings as controls for obesity Clin Exp Dermatol. 34 2 140 4 19018791
49. L Naldi L Chatenoud D Linder A Belloni Fortina A Peserico AR Virgili, et al. 2005 Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study J Invest Dermatol. 125 1 61 7 15982303 1:CAS:528:DC%2BD2MXmvVyku7Y%3D (Pubitemid 40981424)
50. Y Wang J Chen Y Zhao L Geng F Song HD Chen 2008 Psoriasis is associated with increased levels of serum leptin Br J Dermatol. 158 2 1134 5 18294316 1:STN:280:DC%2BD1c3ksFantw%3D%3D (Pubitemid 351521426)
51. P Gisondi G Tessari A Conti S Piaserico S Schianchi A Peserico, et al. 2007 Prevalence of metabolic syndrome in patients with psoriasis: a hospital based case-control study Br J Dermatol. 157 1 68 73 17553036 1:STN:280:DC%2BD2szmsVSqtQ%3D%3D (Pubitemid 46934281)
52. AR Setty G Curhan HK Choi 2007 Obesity, waist circumference, weight change, and risk of psoriasis in women Arch Intern Med. 167 15 1670 5 17698691 (Pubitemid 47280349)
53. RH Eckel SM Grundy PZ Zimmer 2005 The metabolic syndrome Lancet. 365 9468 1415 28 15836891 1:CAS:528:DC%2BD2MXjsVegtbg%3D (Pubitemid 40523737)
54. DM Sommer S Jenisch M Suchan E Christophers M Weichenthal 2006 Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis Arch Dermatol. 298 7 321 8
55. AD Cohen M Sherf L Vidavsky DA Vardy J Shapiro J Meyerovitch 2008 Association between psoriasis and the metabolic syndrome. A cross-sectional study Dermatology. 216 2 152 5 18216477 1:STN:280:DC%2BD1c%2FmsVSiuw%3D%3D (Pubitemid 351158580)
56. AD Cohen H Gilutz Y Henkin D Zahger J Shapiro DY Bonneh, et al. 2007 Psoriasis and the metabolic syndrome Acta Dermatol Venereol. 87 6 506 9 (Pubitemid 351373394)
57. Bongiorno MR, Doukaki S, Rizzo D, Aricò M. The prevalence of the obesity in patients with moderate to severe psoriasis in Sicily populations. JEADV 2009; [Epub ahead of print]
58. C Huerta E Rivero LA Garcia Rodriguez 2007 Incidence and risk factors for psoriasis in the general population Arch Dermatol. 143 12 1559 65 18087008 (Pubitemid 350277774)
59. L Naldi L Peli F Parazzini 1999 Association of early-stage psoriasis with smoking and male alcohol consumption: evidence from an Italian case-control study Arch Dermatol. 135 12 1479 84 10606053 1:STN:280:DC%2BD3c%2Fnt1Sluw%3D%3D
60. CM Mills ED Srivastava IM Harvey GL Swift RG Newcombe PJ Holt, et al. 1992 Smoking habits in psoriasis: a case control study Br J Dermatol. 127 1 18 21 1637689 1:STN:280:DyaK38zksFSmsg%3D%3D
61. L Naldi F Parazzini A Brevi A Peserico C Veller Fornasa G Grosso, et al. 1992 Family history, smoking habits, alcohol consumption and risk of psoriasis Br J Dermatol. 127 3 212 7 1390163 1:STN:280:DyaK3s%2Fgt1eksQ%3D%3D
62. P Wolkenstein J Revuz JC Roujeau G Bonnelye JJ Grob S Bastuji-Garin 2009 Psoriasis in France and associated risk factors: results of a case-control study based on a large community survey Dermatology. 218 2 103 9 19060463 1:STN:280:DC%2BD1M7gsVSntw%3D%3D
63. S Davidsson K Blomqvist L Molin, et al. 2005 Lifestyle of Nordic people with psoriasis Intl J Dermatol. 44 5 378 83 (Pubitemid 40691982)
64. AR Setty G Curhan HK Choi 2007 Smoking and the Risk of Psoriasis in Women: Nurses' Health Study II Am J Med. 120 11 953 9 17976422 (Pubitemid 350011082)
65. C Fortes S Mastroeni K Leffondre, et al. 2005 Relationship between smoking and clinical severity of psoriasis Arch Dermatol. 141 12 1580 4 16365261 (Pubitemid 41815850)
66. Y Jin S Yang F Zhang Y Kong F Xiao Y Hou, et al. 2009 Combined effects of HLA-Cw6 and cigarette smoking in psoriasis vulgaris: A hospital-based case-control study in China J Eur Acad Dermatol Venereol. 23 2 132 7 18702622
67. X Zhang H Wang H Te-shao S Yang F Wang 2002 Frequent use of tobacco and alcohol in Chinese psoriasis patients Intl J Dermatol. 41 10 659 62 (Pubitemid 35252041)
68. S Jankovic M Raznatovic J Marinkovic J Jankovic N Maksimovic 2009 Risk factors for psoriasis: a case-control study J Dermatol. 36 6 328 34 19500181
69. JAH O'Keefe KA Bybee CJ Lavie 2007 Alcohol and cardiovascular health: the razor-sharp double edged sword J Am Coll Cardiol. 50 11 1019 24
70. K Poikolainen J Karvonen E Pukkala 1999 Excess mortality related to alcohol and smoking among hospital-treated patient with psoriasis Arch Dermatol. 135 12 1490 3 10606054 1:STN:280:DC%2BD3c%2Fnt1Sksg%3D%3D
71. CJ McDonald P Calabresi 1978 Psoriasis and occlusive vascular disease Br J Dermatol. 99 469 75 708620 1:STN:280:DyaE1M%2FktF2ltA%3D%3D (Pubitemid 9048948)
72. JM Gelfand AL Neimann DB Shin X Wang DJ Margolis AB Troxel 2006 Risk of myocardial infarction in patients with psoriasis JAMA. 296 14 1735 41 17032986 1:CAS:528:DC%2BD28XhtVyjs77F (Pubitemid 44547793)
73. DD Gladman M Ang L Su BD Tom CT Schentag VT Farewell 2009 Cardiovascular morbidity in psoriatic arthritis (PsA) Ann Rheum Dis. 68 7 1131 5 18697777 1:STN:280:DC%2BD1MvhsFWgtQ%3D%3D
74. YB Brauchli SS Jick M Miret CR Meier 2009 Psoriasis and risk of incident myocardial infarction, stroke or transient ischaemic attack: an inception cohort study with a nested case-control analysis Br J Dermatol. 160 5 1048 56 19210501 1:STN:280:DC%2BD1MzisVOnsg%3D%3D
75. Wakkee M, Herings RM, Nijsten T. Psoriasis may not be an independent risk factor for acute ischemic heart disease hospitalizations: results of a large population-based Dutch cohort. J Invest Dermatol. 2009;[Epub ahead of print]
76. J Xiao LH Chen YT Tu XH Deng J Tao 2009 Prevalence of myocardial infarction in patients with psoriasis in central China J Eur Acad Dermatol Venereol. 23 11 1311 5 19522710 1:STN:280:DC%2BD1Mnos12gsA%3D%3D
77. RJ Ludwig C Herzog A Rostock FR Ochsendorf TM Zollner D Thaci, et al. 2007 Psoriasis: a possible risk factor for development of coronary artery calcification Br J Dermatol. 156 2 271 6 17223866 1:STN:280: DC%2BD2s%2FislaitA%3D%3D (Pubitemid 46095954)
78. C Gonzalez-Juanetey E Amigo-Diaz JA Miranda-Filloy A Testa J Revuelta C Garcia Purrua, et al. 2006 Lack of echocardiographic and Doppler abnormalities in psoriatics arthritis patients without clinically evident cardiovascular disease or classic arthrosclerosis risk factors Semin Arthritis Rheum. 35 5 333 9
79. S Prodanovich RS Kirsner JD Kravetz F Ma L Martinez DG Federman 2009 Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality Arch Dermatol. 145 6 700 3 19528427
80. JM Gelfand ED Dommasch DB Shin RS Azfar SK Kurd X Wang, et al. 2009 The risk of stroke in patients with psoriasis J Invest Dermatol. 129 10 2411 8 19458634 1:CAS:528:DC%2BD1MXhtFWqu77E
81. RS Stern R Lange 1988 Cardiovascular disease, cancer, and cause of death in patients with psoriasis: 10 years prospective experience in a cohort of 1,380 patients J Invest Dermatol. 91 3 197 201 3411140 1:STN:280:DyaL1czhsFyhsw%3D%3D
82. JM Gelfand AB Troxel JD Lewis SK Kurd DB Shin X Wang, et al. 2007 The risk of mortality in patients with psoriasis Arch Dermatol. 143 12 1493 9 18086997
83. L Mallbris O Akre F Granath L Yin B Lindelof A Ekbom, et al. 2004 Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients Eur J Epidemiol. 19 3 225 30 15117115 (Pubitemid 38461682)
84. K Wong DD Gladman J Husted JA Long 1997 Farewell VT. Mortality studies in psoriatic arthritis: results from a single outpatient clinic. I. Causes and risk of death Arthritis Rheum. 40 10 1868 72 9336423 1:STN:280: DyaK2svns1WksA%3D%3D (Pubitemid 27452539)
85. L Naldi L Chatenoud A Belloni A Peserico N Balato AR Virgili, et al. 2008 Medical history, drug exposure and the risk of psoriasis: Evidence from an Italian case-control study Dermatology. 216 2 125 30 18216474 (Pubitemid 351158576)
86. LA Tam B Tomlinson TT Chu M Li YY Leung LW Kwok, et al. 2008 Cardiovascular risk profile of patients with psoriatic arthritis compared to controls- the role of inflammation Rheumatol. 47 5 718 23 (Pubitemid 351619219)
87. A Grzybowski G Grzybowski A Druzdz R Zaba 2001 Evaluation of glucose, insulin, C-peptide uric acid serum levels in patients with psoriasis Pol Merkur Lekarski. 11 66 495 8 11899846 1:CAS:528:DC%2BD38XosFyisbk%3D
88. O Karabudak RE Ulusoy AA Erikci E Solmazgul B Dogan Y Harmanyeri 2008 Inflammation and hypercoaguable state in adult psoriatic men Acta Derm Venereol. 88 4 337 40 18709301 1:CAS:528:DC%2BD1MXjsVKmtbk%3D (Pubitemid 352029507)
89. P Rocha-Pereira A Santos-Silva I Rebelo A Figueiredo A Quintanilha F Teixeira 2004 The inflammatory response in mild and severe psoriasis Br J Dermatol. 150 5 917 28 15149504 1:CAS:528:DC%2BD2cXlt1Kgu74%3D (Pubitemid 38903524)
90. S Boehncke D Thaci H Beschmann RJ Ludwig H Ackermann K Badenhoop, et al. 2007 Psoriasis patients show signs of insulin resistance Br J Dermatol. 157 6 1249 51 17916217 1:STN:280:DC%2BD2snotl2qsQ%3D%3D (Pubitemid 350115673)
91. AD Cohen J Dreiher Y Shapiro L Vidavsky DA Vardy B Davidovici, et al. 2008 Psoriasis and diabetes: a population-based cross-sectional study J Eur Acad Dermatol Venereol. 22 5 585 9 18331320 1:STN:280:DC%2BD1c3kvVynsQ%3D%3D (Pubitemid 351541054)
92. L Markuszeski A Bissinger I Janusz J Narbutt AS Jedrzejowska A Zalewska 2007 Heart rate and arrhythmia in patients with psoriasis vulgaris Arch Med Res. 38 1 64 9 17174725 (Pubitemid 44894613)
93. M Shbeeb KM Uramoto LE Gibson WM O'Fallon SE Gabriel 2000 The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982-1991 J Rheumatol. 27 5 1247 50 10813295 1:STN:280:DC%2BD3c3ntFCjsQ%3D%3D (Pubitemid 30262512)
94. DD Gladman VT Farewell K Wong J Husted 1998 Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death Arth Rheum. 41 6 1103 10 1:STN:280:DyaK1c3ovVOisg%3D%3D (Pubitemid 28265412)
95. HA Miot LD Miot PS Lopes GR Haddad SA Marques 2009 Association between palmoplantar pustulosis and cigarette smoking in Brazil: a case-control study J Eur Acad Dermatol Venereol. 23 10 1173 7 19453779 1:STN:280: DC%2BD1MnjtVSmtw%3D%3D
96. S Coimbra H Oliveira F Reis L Belo S Rocha A Quintanilha, et al. 2009 Circulating levels of adiponectin, oxidized LDL and C-reactive protein in Portuguese patients with psoriasis vulgaris, according to body mass index, severity and duration of the disease J Dermatol Sci. 55 3 202 4 19576730 1:CAS:528:DC%2BD1MXptVSgsr8%3D
97. H Takahashi H Tsuji I Takahashi Y Hashimoto A Ishida-Yamamoto H Iizuka 2009 Prevalence of obesity/adiposity in Japanese psoriasis patients: adiposity is correlated with the severity of psoriasis J Dermatol Sci. 55 1 74 6 19697459
98. DR Bajaj SM Mahesar BR Devrajani MP Iqbal 2009 Lipid profile in patients with psoriasis presenting at Liaquat University Hospital Hyderabad J Pak Med Assoc. 59 8 512 5 19757693
99. K Poikolainen T Reunala J Karvonen J Lauharanta P Kärkkäinen 1990 Alcohol intake: a risk factor for psoriasis in young and middle aged men? BMJ. 300 6727 780 3 1969757 1:STN:280:DyaK3c3htlSitw%3D%3D (Pubitemid 20109272)
100. K Poikolainen T Reunala J Karvonen 1994 Smoking, alcohol and life events related to psoriasis among women Br J Dermatol. 130 4 473 7 8186112 1:STN:280:DyaK2c3kt1Khtw%3D%3D (Pubitemid 24204666)
101. T Henseler E Christophers 1995 Disease concomitance in psoriasis J Am Acad Dermatol. 32 6 982 6 7751469 1:STN:280:DyaK2M3ntVOqtg%3D%3D
102. B Lindegard 1986 Diseases associated with psoriasis in a general population of 159,200 middle-aged, urban, native Swedes Dermatologica. 172 298 304 3089849 1:STN:280:DyaL283nsFGisg%3D%3D (Pubitemid 16014779)
103. PM Ridker 2003 High-sensitivity C-reactive protein and cardiovascular risk: Rationale for screening and primary prevention Am J Cardiol. 92 suppl 17K 22K 12948872 1:CAS:528:DC%2BD3sXnvVSht70%3D
104. F Wolfe B Freundlich WL Straus 2003 Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis J Rheumatol. 30 1 36 40 12508387 (Pubitemid 36077769)
105. EY Rhew R Ramsey-Goldman 2006 Premature atherosclerotic disease in systemic lupus erythematosus-role of inflammatory mechanisms Autoimmun Rev. 5 2 101 5 16431336 1:CAS:528:DC%2BD28XisFWqs7w%3D (Pubitemid 43129536)
106. S Prodanovich ML Shelling DG Federman RS Kirsner 2008 Cytokine milieu in psoriasis and cardiovascular disease may explain the epidemiological findings relating these 2 diseases Arch Dermatol. 144 11 1518 9 19015432